bf/NASDAQ:VKTX_icon.jpeg

COM:VIKINGTHERAPEUTICS

Viking Therapeutics, Inc.

  • Stock

USD

Last Close

51.63

22/11 21:00

Market Cap

6.39B

Beta: -

Volume Today

2.63M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
64.06K
-
952.41K
1,386.75%
1.21M
27.21%
898.15K
25.87%
1.37M
52.19%
1.24M
8.96%
1.70M
36.20%
3.21M
89.35%
2.72M
15.38%
4.99M
83.60%
8.02M
60.84%
average receivables
book value per share
-0.06
-
-5.13
8,730.08%
1.37
126.74%
0.49
64.01%
0.52
4.90%
5.17
897.67%
3.85
25.53%
3.37
12.60%
2.62
22.30%
1.89
27.68%
3.69
95.25%
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share
0.04
-
0.18
320.81%
2.22
1,165.32%
0.81
63.59%
0.79
1.96%
5.24
561.14%
3.83
26.85%
3.42
10.68%
2.62
23.48%
2.02
22.70%
3.84
89.64%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
1.55
-
0.52
66.65%
0.14
72.96%
0.22
61.41%
0.16
30.65%
0.00
-
0.00
39.90%
0.00
90.16%
0.01
6,641.40%
0.00
63.15%
debt to equity
-1.11
-
-0.07
93.63%
0.25
447.92%
0.41
64.85%
0.26
36.96%
0.00
-
0.00
38.50%
0.00
90.22%
0.01
7,392.20%
0.00
66.40%
dividend yield
0.00
-
earnings yield
-0.00
-
-0.63
14,863.85%
-1.08
70.13%
-0.76
29.57%
-0.20
74.35%
-0.05
74.33%
-0.04
10.82%
-0.09
97.46%
-0.15
72.41%
-0.09
38.65%
-0.05
47.56%
enterprise value
34.58M
-
35.29M
2.06%
23.06M
34.67%
19.57M
15.14%
99.93M
410.77%
415.71M
315.99%
569.40M
36.97%
379.96M
33.27%
328.77M
13.47%
687.17M
109.01%
1.70B
147.62%
enterprise value over ebitda
-284.13
-
-1.66
99.42%
-1.03
38.07%
-1.51
47.24%
-5.18
242.06%
-19.20
270.79%
-22.31
16.17%
-8.90
60.11%
-5.90
33.65%
-9.77
65.54%
-16.88
72.68%
ev to operating cash flow
-441.98
-
-22.18
94.98%
-2.64
88.09%
-1.77
33.08%
-6.77
283.18%
-22.17
227.33%
-23.00
3.78%
-17.45
24.15%
-6.91
60.40%
-14.20
105.51%
-23.19
63.32%
ev to sales
free cash flow per share
-0.02
-
-0.37
1,934.16%
-1.37
272.05%
-0.68
50.49%
-0.57
16.47%
-0.33
42.66%
-0.34
5.60%
-0.30
12.79%
-0.62
105.49%
-0.63
2.19%
-0.78
23.47%
free cash flow yield
-0.00
-
-0.05
1,934.16%
-0.40
772.84%
-0.57
41.87%
-0.14
75.52%
-0.04
69.57%
-0.04
0.73%
-0.05
24.23%
-0.13
151.50%
-0.07
49.99%
-0.04
37.63%
graham net net
-0.06
-
-5.67
9,612.75%
1.16
120.52%
0.41
64.82%
0.46
12.18%
5.16
1,024.03%
3.73
27.65%
3.25
12.79%
2.50
23.04%
1.72
31.25%
3.63
110.56%
graham number
0.21
-
24.22
11,394.87%
10.66
55.97%
3.17
70.26%
3.04
4.18%
6.68
119.68%
5.57
16.56%
6.13
10.07%
6.42
4.62%
6.11
4.78%
8.70
42.37%
income quality
0.53
-
0.07
86.41%
0.37
413.03%
0.75
101.44%
0.72
4.57%
0.85
18.53%
0.96
12.95%
0.55
42.57%
0.87
56.94%
0.70
18.79%
0.85
21.56%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-4.12
-
-37.33
806.64%
-12.21
67.28%
-7.65
37.36%
-14.87
94.34%
-64.75
335.53%
47.28
-
interest debt per share
0.07
-
0.51
624.40%
0.49
3.28%
0.31
36.71%
0.18
41.61%
0.01
96.15%
0.01
31.12%
0.00
46.25%
0.00
92.40%
0.00
163.31%
0.01
1,250.15%
inventory turnover
invested capital
-1.11
-
-0.07
93.63%
0.25
447.92%
0.41
64.85%
0.26
36.96%
0.00
-
0.00
38.50%
0.00
90.22%
0.01
7,392.20%
0.00
66.40%
market cap
34.48M
-
34.48M
0%
21.67M
37.14%
19.37M
10.62%
105.47M
444.47%
440.49M
317.64%
577.11M
31.02%
408.72M
29.18%
355.11M
13.12%
722.24M
103.38%
1.76B
143.10%
net current asset value
-251.38K
-
-24.40M
9,605.66%
8.49M
134.79%
7.48M
11.85%
13.20M
76.36%
297.57M
2,155.14%
276.36M
7.13%
243.95M
11.73%
201.75M
17.30%
143.83M
28.71%
347.15M
141.36%
net debt to ebitda
-0.81
-
-0.04
95.31%
-0.06
61.35%
-0.02
75.65%
0.29
2,010.93%
1.14
298.83%
0.30
73.59%
0.67
122.80%
0.47
29.76%
0.50
5.44%
0.54
7.89%
net income per share
-0.03
-
-5.08
14,863.85%
-3.68
27.48%
-0.90
75.42%
-0.79
12.47%
-0.38
51.63%
-0.36
6.51%
-0.50
38.62%
-0.70
40.87%
-0.88
25.36%
-0.91
3.82%
operating cash flow per share
-0.02
-
-0.37
1,934.16%
-1.37
272.05%
-0.68
50.49%
-0.57
16.47%
-0.33
42.66%
-0.34
5.60%
-0.30
12.79%
-0.62
105.49%
-0.63
2.19%
-0.78
23.47%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.81
-
-7.19
787.04%
-1.52
78.92%
-1.01
33.14%
-0.93
8.22%
-0.07
92.15%
-0.09
24.26%
-0.14
54.98%
-0.26
82.39%
-0.40
55.96%
-0.23
41.70%
revenue per share
roe
0.58
-
0.99
69.46%
-2.68
371.24%
-1.83
31.72%
-1.53
16.56%
-0.07
95.15%
-0.09
25.54%
-0.15
58.60%
-0.27
81.30%
-0.46
73.33%
-0.25
46.83%
roic
-4.19
-
1.17
127.99%
-1.15
197.87%
-1.39
20.60%
-1.23
11.34%
-0.08
93.73%
-0.12
52.33%
-0.16
35.36%
-0.27
70.40%
-0.46
71.24%
-0.29
38.04%
sales general and administrative to revenue
shareholders equity per share
-0.06
-
-5.13
8,730.08%
1.37
126.74%
0.49
64.01%
0.52
4.90%
5.17
897.67%
3.85
25.53%
3.37
12.60%
2.62
22.30%
1.89
27.68%
3.69
95.25%
stock based compensation to revenue
tangible asset value
-250.60K
-
-22.13M
8,730.08%
8.72M
139.43%
8.04M
7.82%
13.46M
67.41%
297.75M
2,111.32%
277.12M
6.93%
244.34M
11.83%
201.88M
17.38%
145.32M
28.02%
348.42M
139.76%
tangible book value per share
-0.06
-
-5.13
8,730.08%
1.37
126.74%
0.49
64.01%
0.52
4.90%
5.17
897.67%
3.85
25.53%
3.37
12.60%
2.62
22.30%
1.89
27.68%
3.69
95.25%
working capital
52.13K
-
-21.74M
41,811.55%
13.22M
160.82%
7.50M
43.30%
13.20M
75.98%
297.58M
2,155.23%
276.72M
7.01%
243.97M
11.83%
201.75M
17.31%
145.09M
28.08%
348.09M
139.91%

All numbers in USD (except ratios and percentages)